A clinical study of two formulations, tila bakuchi churna internally and nimbadi lepa externally in patients with dadru (dermatophytosis).

An open label single arm clinical study on the combined effectiveness of tila bakuchi churna and nimbadi lepa in dadru (dermatophytosis) - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054456

Enrollment

Registered

2023-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants suffering with Dadru (dermatophytosis) up to 1 year of duration. 2. Participants of either gender. 3. Participants aged between 18-6023 years. 4. Participants willing to participate in the study and ready to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participants with uncontrolled diabetes mellitus (HbA1C >8). 2. Pregnant women and lactating mother. 3. Participants with any systemic disease with impaired cardiac, hepatic and renal functions which interferes with the course of the treatment, will be excluded.

Design outcomes

Primary

Measure	Time frame
1. Kandu (itching) 2. Raga (erythema) 3. Pidaka (eruption) 4. Mandala (annular scaly patches) 5. Rookshata (dryness) 5-D Pruritus ScaleTimepoint: 30 days	—

Secondary

Measure	Time frame
Dermatology life quality index (DLQI)Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Girish K J

Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital, Hassan, Karnataka

girideepa@yahoo.co.in9448646855

Outcome results